JAZZ
JAZZ clinical trials: Jazz Pharmaceuticals plc
Every trial on ClinicalTrials.gov where Jazz Pharmaceuticals plc is the lead sponsor or a listed collaborator, the trials it leads first, each labelled Lead or Collaborator. Phase, status and dates as registered.
- 296
- Trials linked
- 206
- As lead sponsor
- 90
- As collaborator
- 2
- Primary completions as lead sponsor, next 90 days
JAZZ on the catalyst calendar · JAZZ registry changes
- Primary completion Jul 15, 2026ActualPhase 3NCT05152147A Study of Zanidatamab in Combination With Chemotherapy Plus or Minus Tislelizumab in Patients With HER2-positive Advanced or Metastatic...Jazz Pharmaceuticals · Gastric NeoplasmsActive, not recruitingJAZZLeadONCCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 1, 2028Sponsor estimatePhase 3NCT06282575Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary...Jazz Pharmaceuticals · Biliary Tract CancerRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 29, 2027Sponsor estimatePhase 2NCT07102381A Phase 2 Neoadjuvant Study of Zanidatamab in Combination With Chemotherapy in Participants With HER2-positive Breast CancerJazz Pharmaceuticals · HER2-positive Breast CancerRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 28, 2028Sponsor estimatePhase 4NCT07728097A Study to Investigate the Effect of Gradual Titration to Optimize Cannabidiol Treatment in Adults With LGSJazz Pharmaceuticals · Lennox-Gastaut SyndromeNot yet recruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Sep 4, 2029Sponsor estimatePhase 3NCT07723976A Study to Evaluate the Safety and Efficacy of CBD-OS in Participants With DEEJazz Pharmaceuticals · Developmental and Epileptic Encephalopathy (DEE)RecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 23, 2027Sponsor estimatePhase 3NCT07625280A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IHJazz Pharmaceuticals · NarcolepsyRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 31, 2033Sponsor estimateNo phase registeredNCT06113237Pregnancy Surveillance Program of Patients Exposed to Epidiolex/Epidyolex During PregnancyJazz Pharmaceuticals · Maternal ComplicationsRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2028Sponsor estimatePhase 2/Phase 3NCT07723963A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic EpilepsyJazz Pharmaceuticals · Juvenile Myoclonic EpilepsyRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 31, 2027Sponsor estimatePhase 1NCT04541082Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System NeoplasmsJazz Pharmaceuticals · Central Nervous System NeoplasmsActive, not recruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 4, 2029Sponsor estimatePhase 2NCT07459634A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLCJazz Pharmaceuticals · Extensive-stage Small-cell Lung CancerRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Jan 28, 2028Sponsor estimatePhase 1/Phase 2NCT05734066Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing SarcomaJazz Pharmaceuticals · Refractory Ewing SarcomaRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Feb 27, 2027Sponsor estimatePhase 1NCT07813663A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of JZP269 in Healthy Male and Female ParticipantsJazz Pharmaceuticals · Healthy ParticipantsRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 31, 2026Sponsor estimatePhase 2NCT06695845A Phase 2 Study of Zanidatamab in Patients With HER2-expressing TumorsJazz Pharmaceuticals · Breast CancerRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 25, 2026ActualNo phase registeredNCT05772429Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life SettingJazz Pharmaceuticals · SeizuresCompletedJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 25, 2028Sponsor estimatePhase 2NCT07533942A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 MeningiomaJazz Pharmaceuticals · MeningiomaRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Dec 15, 2028Sponsor estimatePhase 2NCT07282587Study of ONC206 (JZP3507) in Advanced Pheochromocytoma and ParagangliomaJazz Pharmaceuticals · Advanced Pheochromocytoma and ParagangliomaRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 29, 2027Sponsor estimatePhase 1NCT07233239A Study to Evaluate the Efficacy and Safety of Cannabidiol Oral Solution (CBD-OS [GWP42003-P, JZP926]) for the Treatment of Focal-Onset...Jazz Pharmaceuticals · Focal SeizuresRecruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Nov 30, 2026Sponsor estimatePhase 1NCT07377539A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Food Effect of JZP047 in Healthy ParticipantsJazz Pharmaceuticals · Healthy ParticipantsActive, not recruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Oct 1, 2031Sponsor estimateNo phase registeredNCT07780968Zanidatamab Outcomes and Lived Experiences in Advanced HER2+ GEAJazz Pharmaceuticals · Esophageal CancerNot yet recruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 30, 2025ActualPhase 2NCT03929666A Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including...Jazz Pharmaceuticals · HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerCompletedJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 1, 2028Sponsor estimatePhase 1NCT05557045A Study of JZP815 Oral Capsules in Adult Participants With Advanced or Metastatic Solid Tumors Harboring Mitogen Activated Protein...Jazz Pharmaceuticals · Advanced CancerActive, not recruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Apr 28, 2023ActualPhase 2NCT04224272Phase 2a Study of ZW25 in Combination With Palbociclib Plus FulvestrantJazz Pharmaceuticals · HER2+/HR+ Breast CancerCompletedJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 1, 2027Sponsor estimatePhase 4NCT05044819Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral SolutionJazz Pharmaceuticals · Lennox Gastaut SyndromeActive, not recruitingJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Mar 13, 2025ActualPhase 4NCT05875974A Study to Investigate the Effect of XYWAV on Sleepiness, Polysomnography, and Functional Outcomes in Participants With Idiopathic...Jazz Pharmaceuticals · Idiopathic HypersomniaCompletedJAZZLead
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
- Primary completion Aug 29, 2025ActualPhase 1/Phase 2NCT05027139A Study of Zanidatamab (ZW25) With Evorpacept (ALX148) in Patients With Advanced HER2-expressing CancerJazz Pharmaceuticals · HER2-expressing CancersCompletedJAZZLeadALXOCollaborator
- Enrollment
- Locked
- Completion
- Locked
- Interventions
- Locked
Enrollment, interventions and the start and completion dates are locked on 25 rows here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.
Unlock with TrialScannerShowing the first 25 trials. There are 271 more in this window; the full list is part of TrialScanner.
Unlock with TrialScanner